Prognostic significance of programmed cell death ligand 1 blood markers in non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Zhang, Ningning; Chang, Jianlan; Liu, Ping; Tian, Xiangyang; Yu, Junyan

Zhang, Ningning; Chang, Jianlan; Liu, Ping; Tian, Xiangyang; Yu, Junyan.

Affiliation

Zhang N; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.
Chang J; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.
Liu P; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.
Tian X; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.
Yu J; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.

Front Immunol ; 15: 1400262, 2024.

Article in En | MEDLINE | ID: mdl-38915398

Subject(s)
Key words

blood biomarker; immune checkpoint inhibitors; meta-analysis; non-small cell lung cancer; programmed cell death ligand 1

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / B7-H1 Antigen / Immune Checkpoint Inhibitors / Lung Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2024 Document type: Article Affiliation country: China Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google